Apollomics vs Marengo Therapeutics

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and combination cancer therapies

26 employees · est. 2015 · Foster City, United States

Marengo Therapeutics

A new frontier in the fight against cancer– the right activation of the right immune cells

41 employees · est. 2015 · Cambridge, United States

Side-by-Side Comparison

Metric	Apollomics	Marengo Therapeutics
Founded
Founded	2015	2015
Headquarters
Headquarters	Foster City, United States	Cambridge, United States
Employees
Employees	26	41
Industry
Industry	Biotechnology, Health Care, Pharmaceutical	Health Care
Funding Stage
Funding Stage	Post-IPO Equity	Series B
Total Funding
Total Funding	$262.60M	$80.00M
Funding Rounds
Funding Rounds	5	2
Taxonomy
Taxonomy	Biopharmaceutical CompanyOncology TherapiesCombination TherapiesCancer TreatmentDrug DevelopmentImmune System +8	Biotech CompanyClinical StageCancer TreatmentImmunotherapyT Cell ActivationImmune System +8
Website
Website	apollomicsinc.com	marengotx.com

About Apollomics

Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in both the U.S. and China, aiming to harness synergies by collaborating with biotechnology companies in...

View Full Profile Alternatives

About Marengo Therapeutics

Marengo Therapeutics: Marengo Therapeutics, a clinical stage biotech company, is pioneering an entirely new way to activate the body’s own immune system to mount a rapid, effective, and durable response against cancer. Their unique therapeutic platform selectively boosts T cells, turbocharging poten...

View Full Profile Alternatives

Also comparing in this category

Comparing more than these two?

Get Apollomics, Marengo Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Apollomics compare?

A PDF of Apollomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Book a 7-day Readout How the Readout works

Frequently Asked Questions

Apollomics was founded in 2015, based in Foster City, United States, with 26 employees. Apollomics is a biopharmaceutical company with a clear mission to discover and develop mono- and combination cancer therapies. Established in 2016, Apollomics has made strategic moves to operate in bo. Marengo Therapeutics was founded in 2015, based in Cambridge, United States, with 41 employees. Marengo Therapeutics: Marengo Therapeutics, a clinical stage biotech company, is pioneering an entirely new way to activate the body’s own immune system to mount a rapid, effective, and durable respon.

Apollomics has raised $262.60M and Marengo Therapeutics $80.00M. Latest stage: Apollomics Post-IPO Equity, Marengo Therapeutics Series B.

Both work in Health Care and list cancer treatment, immune system and immunotherapy among their focus areas.

Compare Apollomics with someone else

Start typing a company name or domain.

Related Comparisons

Apollomics vs Surface Oncology Inc. Apollomics vs TME Pharma Apollomics Alternatives Marengo Therapeutics Alternatives All Companies All Signals

Compiled from the BounceWatch company index. We last looked at Apollomics on 12 Sep 2024, and Marengo Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.